personalis inc. - PSNL

PSNL

Close Chg Chg %
7.70 -0.38 -4.94%

Closed Market

7.32

-0.38 (4.94%)

Volume: 1.37M

Last Updated:

Mar 26, 2026, 4:00 PM EDT

Company Overview: personalis inc. - PSNL

PSNL Key Data

Open

$7.52

Day Range

7.31 - 7.79

52 Week Range

2.83 - 11.50

Market Cap

$805.67M

Shares Outstanding

104.63M

Public Float

62.17M

Beta

2.02

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.91

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.67M

 

PSNL Performance

1 Week
 
6.06%
 
1 Month
 
-15.01%
 
3 Months
 
-5.41%
 
1 Year
 
112.71%
 
5 Years
 
-65.14%
 

PSNL Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 7
Full Ratings ➔

About personalis inc. - PSNL

Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.

PSNL At a Glance

Personalis, Inc.
6600 Dumbarton Circle
Fremont, California 94555
Phone 1-650-752-1300 Revenue 69.65M
Industry Medical/Nursing Services Net Income -81,270,000.00
Sector Health Services Employees 260
Fiscal Year-end 12 / 2026
View SEC Filings

PSNL Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 10.199
Price to Book Ratio 3.123
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -6.553
Enterprise Value to Sales 7.34
Total Debt to Enterprise Value 0.08

PSNL Efficiency

Revenue/Employee 267,876.923
Income Per Employee -312,576.923
Receivables Turnover 4.298
Total Asset Turnover 0.23

PSNL Liquidity

Current Ratio 6.739
Quick Ratio 6.606
Cash Ratio 6.055

PSNL Profitability

Gross Margin 22.652
Operating Margin -126.431
Pretax Margin -116.657
Net Margin -116.687
Return on Assets -26.891
Return on Equity -35.019
Return on Total Capital -26.911
Return on Invested Capital -30.561

PSNL Capital Structure

Total Debt to Total Equity 15.625
Total Debt to Total Capital 13.513
Total Debt to Total Assets 12.213
Long-Term Debt to Equity 12.531
Long-Term Debt to Total Capital 10.837
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Personalis Inc. - PSNL

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
65.05M 73.48M 84.61M 69.65M
Sales Growth
-23.92% +12.97% +15.15% -17.69%
Cost of Goods Sold (COGS) incl D&A
51.70M 55.27M 57.79M 53.87M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
12.88M 11.30M 10.94M 10.05M
Depreciation
12.88M 11.30M 10.94M 10.05M
Amortization of Intangibles
- - - -
-
COGS Growth
-3.97% +6.92% +4.55% -6.78%
Gross Income
13.35M 18.21M 26.82M 15.78M
Gross Income Growth
-57.83% +36.39% +47.33% -41.19%
Gross Profit Margin
+20.52% +24.78% +31.70% +22.65%
2022 2023 2024 2025 5-year trend
SG&A Expense
128.88M 114.50M 95.09M 103.83M
Research & Development
64.91M 64.78M 48.91M 50.26M
Other SG&A
63.97M 49.73M 46.19M 53.57M
SGA Growth
+32.85% -11.16% -16.95% +9.19%
Other Operating Expense
- - - -
-
Unusual Expense
- - - 13.64M
-
EBIT after Unusual Expense
(115.53M) (109.94M) (68.27M) (88.06M)
Non Operating Income/Expense
2.46M 1.83M (12.97M) 7.01M
Non-Operating Interest Income
2.40M 5.90M 5.51M 7.16M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
201.00K 110.00K 24.00K 205.00K
Interest Expense Growth
+9.24% -45.27% -78.18% +754.17%
Gross Interest Expense
201.00K 110.00K 24.00K 205.00K
Interest Capitalized
- - - -
-
Pretax Income
(113.28M) (108.21M) (81.27M) (81.25M)
Pretax Income Growth
-73.70% +4.47% +24.90% +0.02%
Pretax Margin
-174.14% -147.27% -96.04% -116.66%
Income Tax
40.00K 83.00K 18.00K 21.00K
Income Tax - Current - Domestic
5.00K (6.00K) 4.00K 5.00K
Income Tax - Current - Foreign
66.00K 35.00K 15.00K 18.00K
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
(31.00K) 54.00K (1.00K) (2.00K)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(113.31M) (108.30M) (81.28M) (81.27M)
Minority Interest Expense
- - - -
-
Net Income
(113.31M) (108.30M) (81.28M) (81.27M)
Net Income Growth
-73.73% +4.43% +24.94% +0.02%
Net Margin Growth
-174.20% -147.38% -96.06% -116.69%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(113.31M) (108.30M) (81.28M) (81.27M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(113.31M) (108.30M) (81.28M) (81.27M)
EPS (Basic)
-2.4793 -2.248 -1.3719 -0.9107
EPS (Basic) Growth
-66.82% +9.33% +38.97% +33.62%
Basic Shares Outstanding
45.70M 48.18M 59.25M 89.24M
EPS (Diluted)
-2.4793 -2.248 -1.3719 -0.9107
EPS (Diluted) Growth
-66.82% +9.33% +38.97% +33.62%
Diluted Shares Outstanding
45.70M 48.18M 59.25M 89.24M
EBITDA
(102.65M) (85.00M) (57.33M) (78.01M)
EBITDA Growth
-82.04% +17.20% +32.56% -36.08%
EBITDA Margin
-157.81% -115.67% -67.75% -112.01%

Snapshot

Average Recommendation BUY Average Target Price 11.571
Number of Ratings 7 Current Quarters Estimate -0.269
FY Report Date 03 / 2026 Current Year's Estimate -1.078
Last Quarter’s Earnings -0.26 Median PE on CY Estimate N/A
Year Ago Earnings -0.91 Next Fiscal Year Estimate -0.94
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 7 7 7 7
Mean Estimate -0.27 -0.27 -1.08 -0.94
High Estimates -0.23 -0.23 -0.98 -0.73
Low Estimate -0.30 -0.31 -1.13 -1.11
Coefficient of Variance -10.85 -11.04 -5.43 -13.68

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 6 6 6
OVERWEIGHT 0 0 0
HOLD 1 1 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Insider Actions for Personalis Inc. - PSNL

Date Name Shares Transaction Value
Jul 31, 2025 Aaron Tachibana CFO AND COO 164,458 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $6.57 per share 1,080,489.06
Jul 31, 2025 Richard O. Chen CHIEF MEDICAL OFFICER AND EVP 124,505 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $6.57 per share 817,997.85
May 21, 2025 Arthur Blaine Bowman Director 50,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 21, 2025 Kenneth J. Widder Director 50,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 21, 2025 Woodrow A. Myers Director 50,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 21, 2025 Lonnie Shoff Director 50,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 21, 2025 Karin Eastham Director 50,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 21, 2025 Stephen M. Moore SVP and Chief Legal Officer 64,200 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $4.95 per share 317,790.00
May 21, 2025 Olivia K. Bloom Director 50,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Personalis Inc. in the News